Insider sale
CASI PHARMACEUTICALS, INC.
$925.9K
134K shares
What this filing means
PANACEA INNOVATION LTD plans to sell 134K shares of CASI PHARMACEUTICALS, INC. valued at approximately $925.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/5/2024ACC: 0000950170-24-026741
134K
Shares to sell
$925.9K
Approx. market value
171.12K
Acquired (3 months)
2
Planned
Securities Acquired — Last 3 Months1
Open Market Purchase
Cash
8/19/2022
171.12KTotal acquired171.12K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/19/2022 | Open Market Purchase Cash | 171.12K | — |
| Total | 171.12K | ||
Planned & Completed Dispositions2
NASDAQPlanned
Units to sell
54K
Market value
$373.1K
3/5/2024
NASDAQPlanned
Units to sell
80K
Market value
$552.8K
3/5/2024
Total
Units
134K
Value
$925.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/5/2024 | 54K | $373.1K | NASDAQ | Planned |
3/5/2024 | 80K | $552.8K | NASDAQ | Planned |
| Total | 134K | $925.9K | ||